Valproic acid inhibits the invasion of PC3 prostate cancer cells by upregulating the metastasis suppressor protein NDRG1

Valproic acid (VPA) is a clinically available histone deacetylase inhibitor with promising anticancer attributes. Recent studies have demonstrated the anticancer effects of VPA on prostate cancer cells. However, little is known about the differential effects of VPA between metastatic and non-metasta...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jae Eun, Kim, Jung Hwa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Sociedade Brasileira de Genética 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763324/
https://www.ncbi.nlm.nih.gov/pubmed/26692161
http://dx.doi.org/10.1590/S1415-475738420150028

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4763324/
https://www.ncbi.nlm.nih.gov/pubmed/26692161
http://dx.doi.org/10.1590/S1415-475738420150028

Ejemplares similares